IP Library Granted Patent US 9,340,771
Granted Patent B2
US 9,340,771 · App. 14/703,407 · Granted May 17, 2016

FGF having enhanced stability

Inventors: Guokai Chen (Rockville, MD); James A. Thomson (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N5/0606C12N5/0696C12N2501/113C12N2501/115C12N2501/119C12N2501/155C12N2501/91C12N2506/02C12N2506/1307
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,340,771
App. No.
14/703,407
Granted
May 17, 2016
Kind
B2
Abstract

Methods are provided that exploit thermostable FGF-1 proteins for support of human pluripotent stem cell cultures. Also provided are compositions containing thermostable FGF-1 for culturing of human pluripotent stem cells.

Claims (12)

1. A method for differentiating a human pluripotent stem cell into a mesoderm lineage cell, the method comprising the step of:

culturing the human pluripotent stem cell in a fully defined culture medium comprising BMP4 and an FGF comprising the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:4 until the cultured cell expresses mesoderm lineage markers.

2. The method of claim 1 , wherein the FGF comprises the amino acid sequence of SEQ ID NO:3.

3. The method of claim 2 , wherein the amino acid sequence of the FGF consists of the amino acid sequence of SEQ ID NO:3.

4. The method of claim 1 , wherein the amino acid sequence of the FGF comprises the amino acid sequence of SEQ ID NO:4.

5. A method for reprogramming a human somatic cell into a human pluripotent stem cell, comprising:

culturing a somatic cell expressing a plurality of reprogramming factors sufficient to induce pluripotency in a fully defined culture medium comprising factors that support pluripotency of human pluripotent stem cells until the cell expresses markers indicative of a human pluripotent stem cell, wherein the medium comprises water, salts, amino acids, vitamins, glucose, insulin, selenium and an FGF comprising the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:4.

6. The method of claim 5 , wherein the FGF comprises the amino acid sequence of SEQ ID NO:3.

7. The method of claim 6 , wherein the amino acid sequence of the FGF consists of the amino acid sequence of SEQ ID NO:3.

8. The method of claim 5 , wherein the FGF comprises the amino acid sequence of SEQ ID NO:4.

9. The method of claim 8 , wherein the amino acid sequence of the FGF consists of the amino acid sequence of SEQ ID NO:4.

10. The method of claim 5 , wherein the medium further comprises heparin.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 17, 2018
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046179/0750 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2017
From: THOMSON, JAMES; CHEN, GUOKAI
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 041190/0029 →
Continuity (3)
Continuation 13717055 · Dec 17, 2012
Provisional Application 61576803 · Dec 16, 2011
Related Publication 20150267166A1 · Sep 24, 2015